Market Overview

CONMED Corporation to Present at the Morgan Stanley Global Healthcare Conference

Share:

CONMED Corporation (NASDAQ:CNMD) today announced that Curt R.
Hartman, President and Chief Executive Officer, and Todd W. Garner,
Executive Vice President and Chief Financial Officer, will present at
the Morgan Stanley Global Healthcare Conference at 9:20 a.m. ET on
Wednesday, September 12, 2018 in New York, NY.

A live webcast of the presentation will be accessible through the
"Investors" section of the Company's website at www.conmed.com
and will be available for replay following the event.

About CONMED Corporation

CONMED is a medical technology company that provides surgical devices
and equipment for minimally invasive procedures. The Company's products
are used by surgeons and physicians in a variety of specialties,
including orthopedics, general surgery, gynecology, neurosurgery,
thoracic surgery and gastroenterology. CONMED has a direct selling
presence in 19 countries, and international sales constitute
approximately 50% of the Company's total sales. Headquartered in Utica,
New York, the Company employs approximately 3,100 people. For more
information, visit www.conmed.com.

Forward-Looking Statements

This press release may contain forward-looking statements based on
certain assumptions and contingencies that involve risks and
uncertainties, which could cause actual results, performance, or trends
to differ materially from those expressed in the forward-looking
statements herein or in previous disclosures. For example, in addition
to general industry and economic conditions, factors that could cause
actual results to differ materially from those in the forward-looking
statements may include, but are not limited to, the risk factors
discussed in the Company's Annual Report on Form 10-K for the fiscal
year ended December 31, 2017, and listed under the heading Forward-Looking
Statements
in the Company's most recently filed Form 10-Q. Any and
all forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995 and
relate to the Company's performance on a going-forward basis. The
Company believes that all forward-looking statements made by it have a
reasonable basis, but there can be no assurance that management's
expectations, beliefs or projections as expressed in the forward-looking
statements will actually occur or prove to be correct.

View Comments and Join the Discussion!